Journal Home
Search for

Volume 16, Issue 3, Pages 344-349 (March 2010)


View previous. 10 of 22 View next.

Successful Hematopoietic Stem Cell Transplantation in 2 Children with X-Linked Chronic Granulomatous Disease from Their Unaffected HLA-Identical Siblings Selected Using Preimplantation Genetic Diagnosis Combined with HLA Typing

Evgenios Goussetis1Corresponding Author Informationemail address, Christopher P. Konialis2, Ioulia Peristeri1, Vasiliki Kitra1, Maria Dimopoulou1, Theoni Petropoulou3, George Vessalas1, Andreas Papassavas4, Marianna Tzanoudaki5, Georgia Kokkali6, Eftychia Petrakou1, Antonia Spiropoulos1, Constantinos G. Pangalos2, Konstantinos Pantos6, Stelios Graphakos1

Received 3 September 2009; accepted 10 October 2009. published online 15 October 2009.

We report 2 children with X-linked chronic granulomatous disease (X-CGD) who underwent hematopoietic stem cell transplantation (HSCT) using grafts from their siblings selected before implantation to be both unaffected and HLA-matched donors. Preimplantation genetic diagnosis (PGD) along with HLA-typing were performed on preimplantation embryos by single-cell multiplex polymerase chain reaction using informative short tandem repeat markers in the HLA locus together with the gene region containing the mutations. Two singleton pregnancies resulted from the intrauterine transfer of selected embryos; these developed to term, producing 1 healthy female and 1 X-CGD carrier female, which are HLA-identical siblings to the 2 affected children. Combined grafts of umbilical cord blood (UCB) and bone marrow (BM) stem cells were administered to the recipients after myeloablative (MA) conditioning at the ages of 4.5 years and 4 years, respectively. Both patients are well, with complete donor hematopoietic and immunologic reconstitution, at 18 and 13 months posttransplantation, respectively. This report demonstrates that HSCT with HLA-matched sibling donors created by PGD/HLA typing of in vitro fertilized embryos is a realistic therapeutic option and should be presented as such to families with children who require a non-urgent HSCT but lack an HLA-genoidentical donor.

1 Stem Cell Transplant Unit, Aghia Sofia Children's Hospital, Athens, Greece

2 Department of Molecular Genetics and Preimplantation Genetic Diagnosis, Intergenetics Hellas, Diagnostic Genetic Center, Athens, Greece

3 First Pediatric Clinic, Aghia Sofia Children's Hospital Medical School, University of Athens, Athens, Greece

4 Hellenic Cord Blood Bank, Foundation for Biomedical Research, Academy of Athens, Athens, Greece

5 Immunology Department, Aghia Sofia Children's Hospital, Athens, Greece

6 Center for Human Reproduction, Genesis Athens Hospital, Athens, Greece

Corresponding Author InformationCorrespondence and reprint requests: Evgenios Goussetis, MD, SCT-Unit, Aghia Sofia Children's Hospital, Thivon and Mikras Asias, 11527 Athens, Greece.

 Financial disclosure: See Acknowledgments on page 348.

PII: S1083-8791(09)00466-2

doi:10.1016/j.bbmt.2009.10.010


View previous. 10 of 22 View next.